Some financial executives are concerned several sectors within the healthcare and life sciences industry are overvalued, according to a survey by KPMG and Leavitt Partners. Here are four findings from the survey, comprising results from 265 finance executives. 1. Thirty-six percent of respondents said ...
Delivered by KPMG Today (@KPMG_TO)
Article continues here
Follow @KPMG_TO on Twitter to get latest updates